XTRA:MRKPharmaceuticals
How Investors Are Reacting To Merck KGaA (XTRA:MRK) Partnering With Promega For 3D Drug Discovery Technologies
MilliporeSigma, the North American Life Science business of Merck KGaA, recently announced a partnership with Promega Corporation to co-develop advanced technologies for drug screening and discovery, integrating expertise in organoids, synthetic chemistry, and cellular assays.
This collaboration aims to provide innovative workflows for real-time tracking of cellular activity and studying protein interactions in 3D cell cultures, reinforcing Merck KGaA's role in life sciences...